Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$63.15 - $72.88 $6.78 Million - $7.83 Million
107,400 Added 68.63%
263,900 $18.1 Million
Q1 2024

May 10, 2024

SELL
$71.58 - $87.29 $15.6 Million - $19 Million
-218,000 Reduced 58.21%
156,500 $11.5 Million
Q4 2023

Feb 09, 2024

SELL
$73.27 - $83.09 $7.33 Million - $8.31 Million
-100,000 Reduced 21.07%
374,500 $30.3 Million
Q3 2023

Nov 09, 2023

BUY
$73.94 - $80.67 $17.5 Million - $19.1 Million
237,000 Added 99.79%
474,500 $35.6 Million
Q2 2023

Aug 10, 2023

BUY
$76.01 - $86.7 $2.28 Million - $2.6 Million
30,000 Added 14.46%
237,500 $18.3 Million
Q1 2023

May 11, 2023

SELL
$77.31 - $88.08 $38.8 Million - $44.2 Million
-501,500 Reduced 70.73%
207,500 $17.2 Million
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $9.35 Million - $13.4 Million
-150,000 Reduced 17.46%
709,000 $60.9 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $3.72 Million - $4.25 Million
62,500 Added 7.85%
859,000 $53 Million
Q2 2022

Aug 10, 2022

SELL
$57.72 - $65.01 $21.8 Million - $24.5 Million
-377,500 Reduced 32.16%
796,500 $49.2 Million
Q1 2022

May 12, 2022

SELL
$57.92 - $72.58 $27.8 Million - $34.8 Million
-480,000 Reduced 29.02%
1,174,000 $69.8 Million
Q4 2021

Feb 10, 2022

BUY
$64.88 - $73.64 $67.8 Million - $77 Million
1,045,000 Added 171.59%
1,654,000 $120 Million
Q3 2021

Nov 10, 2021

BUY
$67.69 - $73.03 $41.2 Million - $44.5 Million
609,000 New
609,000 $42.5 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.